RecruitingNCT06934499
Tunisian Lung Cancer Study
Clinical Observational Study on Tunisian Lung Cancer
Sponsor
Dacima Consulting
Enrollment
1,334 participants
Start Date
May 2, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age more than 18 years
- Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
- Informed consent
Exclusion Criteria1
- None
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06934499
Related Trials
Erector Spinae Block for Thoracic Surgery
NCT055217891 location
Precision Lung Cancer Survivorship Care Intervention
NCT058579951 location
B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.
NCT072361771 location
Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin
NCT059778031 location